Showing results (21-30 of 94) with videos related to

Sort By:
Pageof 10
Therapeutic Advances in Medical Oncology|February 1, 2018
Radiation effects on antitumor immune responses: current perspectives and challengesThomas Walle, Rafael Martinez Monge, Adelheid Cerwenka, et al.
BMC Cancer|January 16, 2019
CYR61 triggers osteosarcoma metastatic spreading via an IGF1Rβ-dependent EMT-like processNadia Habel, Bojana Stefanovska, Dimitri Carène, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 6, 2023
LAMC2 Regulates Key Transcriptional and Targetable Effectors to Support Pancreatic Cancer GrowthOihane Erice, Shruthi Narayanan, Iker Feliu, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|November 13, 2024
DSTYK Inhibition Sensitizes NSCLC to Taxane-Based ChemotherapyMirari Echepare, Beñat Picabea, Andrea Arricibita, et al.
Signal Transduction and Targeted Therapy|June 12, 2025
Dual ENPP1/ATM depletion blunts DNA damage repair boosting radioimmune efficacy to abrogate triple-negative breast cancerBorja Ruiz-Fernández de Córdoba, Karmele Valencia, Connor Welch, et al.
Methods in Cell Biology|February 22, 2026
Establishment single lung tumors through orthotopic injectionBeñat Picabea, Céline Clémenson, Mirari Echepare, et al.
Methods in Cell Biology|February 22, 2026
Metastasis mouse model of breast cancer derived from circulating tumor cells (CTCs) after primary orthotopic tumor resectionÁngela Pérez-Cervera, Haritz Moreno, Helena Villanueva, et al.
International Journal of Cancer|June 18, 2011
Calpain-6 is an endothelin-1 signaling dependent protective factor in chemoresistant osteosarcomaAllison Marion, François-Xavier Dieudonné, Ana Patiño-Garcia, et al.
Cancers|July 18, 2020
Combinatorial Nanomedicine Made of Squalenoyl-Gemcitabine and Edelfosine for the Treatment of OsteosarcomaCarlos Rodríguez-Nogales, Haritz Moreno, Carolina Zandueta, et al.
Nature Communications|February 22, 2017
An integrative approach unveils FOSL1 as an oncogene vulnerability in KRAS-driven lung and pancreatic cancerAdrian Vallejo, Naiara Perurena, Elisabet Guruceaga, et al.
Pageof 10